HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

This adverse event was reported 7512 times

HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EMAPALUMAB-LZSG 72 0.3038
1 ANAKINRA 725 0.0429
2 VANCOMYCIN HYDROCHLORIDE 259 0.0310
3 CANAKINUMAB 297 0.0272
4 BARICITINIB 76 0.0249
5 IDECABTAGENE VICLEUCEL 28 0.0226
6 BREXUCABTAGENE AUTOLEUCEL 47 0.0218
7 CILTACABTAGENE AUTOLEUCEL 133 0.0203
8 TREOSULFAN 50 0.0181
9 AXICABTAGENE CILOLEUCEL 143 0.0141
See all drugs enriched for association with HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS